Bashir Jaffer serves as Executive at CHEMOKINE THERAPEUTICS CORP, where they oversee executive responsibilities. Since joining the company, Bashir Jaffer has executed 1 insider transactions totaling $10.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 7, 2008 involved purchasing 50,000 shares valued at $10.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 7, 2008 | CHKT | $10.0K | Purchase | 50,000 | $0.20 | Discretionary |
Bashir Jaffer currently holds 50,000 shares of CHEMOKINE THERAPEUTICS CORP (CHKT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bashir Jaffer has been a net buyer of CHKT stock. They have purchased $10.0K and sold $0 worth of shares.
Bashir Jaffer's most recent insider trade was on Feb 7, 2008, when they purchased 50,000 shares at $0.20 per share.
Get notified when new Form 4 filings are submitted